Circular Genomics Appoints Dr. Henrik Zetterberg to Advisory Board
Circular Genomics has appointed Dr. Henrik Zetterberg, a prominent expert in neurochemistry and Alzheimer’s fluid biomarkers, to its Scientific Advisory Board. Dr. Zetterberg’s expertise will aid in advancing Circular Genomics’ initiatives to develop blood-based biomarkers for neurodegenerative diseases, particularly focusing on Alzheimer’s. The company’s innovative platform aims to improve diagnosis, risk prediction, and treatment for patients.
Leading Alzheimer’s Disease Researcher Joins to Advance Circular RNA Blood-Based Biomarker Platform for Neurodegenerative Diseases SAN DIEGO, April 24, 2026 /PRNewswire/ — Circular Genomics, a biotechnology company revolutionizing neurological and psychiatric precision medicine through…